Fine Foods & Pharmaceuticals N.T.M. has finalized the translisting to the Euronext Milan, STAR market
July 2021 — Fine Foods Pharmaceuticals N.T.M. SpA has completed the translisting from the Euronext Growth Milan to the Euronext Milan, STAR segment.
Fine Foods & Pharmaceuticals N.T.M. operates as a contract development and manufacturing organization for the pharmaceutical industry. The firm specializes in the distribution of oral solid forms for the pharmaceutical and nutraceutical industries. It also offers medical devices and technologies for granulation and packaging.
Our role in the transaction
Oaklins Italy’s parent company Banca Akros acted as sponsor in the translisting of Fine Foods Pharmaceuticals N.T.M.
Talk to the deal team
Related deals
OEP Danzig BidCo has completed a mandatory tender offer for the shares of Digital Value
OEP Danzig BidCo S.p.A. has completed a mandatory tender offer for the shares of Digital Value S.p.A.
Learn moreVerdane has completed the acquisition of Augmentum Fintech
Following the acceptance of its offer and subsequent shareholder approval, Augmentum Fintech plc has been acquired by Verdane Advisors AS.
Learn moreUKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn more